ISL
MRK icon

Ingalls & Snyder LLC’s Merck MRK Stock Holding History

Ingalls & Snyder LLC’s Portfolio MRK Stock Details MRK Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$24.9M Sell
206,731
-15,698
-7% -$1.81M 0.88% 28
2025
Q4 		$23.4M Sell
222,429
-3,005
-1% -$282K 0.86% 27
2025
Q3 		$18.9M Sell
225,434
-6,314
-3% -$520K 0.62% 31
2025
Q2 		$18.3M Sell
231,748
-2,925
-1% -$233K 0.65% 29
2025
Q1 		$21.1M Sell
234,673
-6,712
-3% -$627K 0.69% 28
2024
Q4 		$24M Sell
241,385
-2,189
-0.9% -$226K 0.94% 25
2024
Q3 		$27.7M Sell
243,574
-3,097
-1% -$368K 1.08% 19
2024
Q2 		$30.5M Sell
246,671
-1,934
-0.8% -$249K 1.31% 15
2024
Q1 		$32.8M Sell
248,605
-10,973
-4% -$1.35M 1.45% 11
2023
Q4 		$28.3M Sell
259,578
-12,001
-4% -$1.25M 1.28% 14
2023
Q3 		$28M Sell
271,579
-916
-0.3% -$98.7K 1.35% 15
2023
Q2 		$31.4M Sell
272,495
-6,985
-2% -$793K 1.51% 12
2023
Q1 		$29.7M Sell
279,480
-1,461
-0.5% -$158K 1.53% 13
2022
Q4 		$31.2M Sell
280,941
-7,439
-3% -$760K 1.7% 11
2022
Q3 		$24.8M Sell
288,380
-2,240
-0.8% -$200K 1.39% 13
2022
Q2 		$26.5M Buy
290,620
+982
+0.3% +$87.1K 1.38% 14
2022
Q1 		$23.8M Buy
289,638
+1,539
+0.5% +$121K 1.06% 21
2021
Q4 		$22.1M Sell
288,099
-10,930
-4% -$871K 1% 24
2021
Q3 		$22.5M Sell
299,029
-16,129
-5% -$1.23M 1.03% 24
2021
Q2 		$24.5M Sell
315,158
-19,149
-6% -$1.42M 1.09% 21
2021
Q1 		$24.6M Buy
334,307
+7,461
+2% +$550K 1.15% 19
2020
Q4 		$25.5M Buy
326,846
+10,905
+3% +$834K 1.26% 17
2020
Q3 		$25M Sell
315,941
-1,545
-0.5% -$121K 1.72% 12
2020
Q2 		$23.4M Buy
317,486
+699
+0.2% +$52.6K 1.35% 15
2020
Q1 		$23.3M Buy
316,787
+12,294
+4% +$966K 1.57% 11
2019
Q4 		$26.4M Sell
304,493
-1,005
-0.3% -$82.5K 1.43% 16
2019
Q3 		$24.5M Sell
305,498
-12,360
-4% -$991K 1.2% 16
2019
Q2 		$25.4M Buy
317,858
+14
+0% +$1.07K 1.22% 15
2019
Q1 		$25.2M Sell
317,844
-5,474
-2% -$409K 1.2% 15
2018
Q4 		$23.6M Sell
323,318
-7,474
-2% -$528K 1.24% 15
2018
Q3 		$22.4M Sell
330,792
-2,143
-0.6% -$137K 0.94% 21
2018
Q2 		$19.3M Sell
332,935
-1,137
-0.3% -$64.1K 0.9% 25
2018
Q1 		$17.4M Sell
334,072
-26,380
-7% -$1.42M 0.85% 28
2017
Q4 		$19.4M Sell
360,452
-11,850
-3% -$657K 0.89% 27
2017
Q3 		$22.7M Buy
372,302
+18,392
+5% +$1.12M 1.18% 17
2017
Q2 		$21.6M Buy
353,910
+8,214
+2% +$500K 1.18% 20
2017
Q1 		$21M Buy
345,696
+5,986
+2% +$363K 1.12% 21
2016
Q4 		$19.1M Sell
339,710
-4,859
-1% -$284K 1.04% 26
2016
Q3 		$20.5M Sell
344,569
-6,902
-2% -$404K 1.14% 23
2016
Q2 		$19.3M Buy
351,471
+7,041
+2% +$375K 1.14% 23
2016
Q1 		$17.4M Buy
344,430
+11,698
+4% +$573K 1.11% 25
2015
Q4 		$16.8M Buy
332,732
+38,392
+13% +$1.94M 1.07% 24
2015
Q3 		$13.9M Buy
294,340
+18,070
+7% +$960K 0.91% 28
2015
Q2 		$15M Buy
276,270
+4,239
+2% +$238K 0.83% 32
2015
Q1 		$14.9M Buy
272,031
+11,833
+5% +$670K 0.82% 32
2014
Q4 		$14.1M Buy
260,198
+22,477
+9% +$1.25M 0.82% 30
2014
Q3 		$13.4M Buy
237,721
+5,544
+2% +$311K 0.72% 34
2014
Q2 		$12.8M Buy
232,177
+3,165
+1% +$173K 0.63% 39
2014
Q1 		$12.4M Buy
229,012
+3,300
+1% +$171K 0.66% 37
2013
Q4 		$10.8M Buy
225,712
+6,031
+3% +$276K 0.59% 42
2013
Q3 		$9.98M Sell
219,681
-4,237
-2% -$193K 0.6% 41
2013
Q2 		$9.92M Buy
+223,918
New +$10M 0.63% 37

Other funds holding MRK

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
Charles Schwab
Charles Schwab San Francisco, California $654B AUM 26.35% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Ingalls & Snyder LLC's MRK Position: Q1 2026 in Review

Ingalls & Snyder LLC reduced its Merck (MRK) stake by 7.1% in Q1 2026, selling an estimated $1.81M and leaving 206,731 shares worth $24.9M. The position accounts for 0.88% of the portfolio, ranked #28.

Ingalls & Snyder LLC first reported a position in MRK in Q2 2013 and has held it in 52 quarters since. The position peaked at $32.8M in Q1 2024. 3,775 funds tracked by Wall St. Rank hold MRK as of Q1 2026.

  • Ingalls & Snyder LLC held 206,731 shares of Merck worth $24.9M as of Q1 2026.
  • Ingalls & Snyder LLC sold 15,698 Merck shares in Q1 2026, an estimated $1.81M.
  • Merck made up 0.88% of Ingalls & Snyder LLC's portfolio in Q1 2026, its #28 holding.
  • Ingalls & Snyder LLC first reported a position in Merck in Q2 2013 and has held it in 52 quarters since.
  • Ingalls & Snyder LLC's Merck position peaked at $32.8M in Q1 2024.
  • 3,775 funds tracked by Wall St. Rank held Merck as of Q1 2026.

Based on Ingalls & Snyder LLC's 13F filing for Q1 2026, filed 13 May 2026.